hme

Precision medicine in B-cell lymphoid malignancies: is it possible?

On demand Janssen satellite symposium from the virtual ESH CLL congress 2021

Back to previous page

Introduction - What do we mean by precision medicine in B-cell lymphoid malignancies? Kostas Stamatopoulos
Structured roundtable panel discussion: Is biology-driven clinical management possible... • in chronic lymphocytic leukemia? • in Waldenström’s macroglobulinemia? • in diffuse large B-cell lymphoma? All faculty, moderated by Kostas Stamatopoulos
Questions and answers • Questions submitted by the audience All faculty, moderated by Kostas Stamatopoulos
Closing remarks Kostas Stamatopoulos

Learning objective:

After participating in this symposium, delegates should be able to:

Discuss the role of precision medicine in the management of patients with B-cell lymphoid malignancies

Faculty:

Kostas Stamatopoulos (Greece)
Gianluca Gaidano (Italy)
Steve Treon (USA)
Catherine Thieblemont (France)

61 Minutes

Faculty

Kostas Stamatopoulos

Gianluca Gaidano

Steve Treon

Catherine Thieblemont

EM-71288 - Date of preparation: August 2021